Feng W - Search Results

1

PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer.

Xia X, Yin W, Zhang X, Yu X, Wang C, Xu S, Feng W, Yang H. Xia X, et al. Among authors: feng w. Oncol Lett. 2015 Sep;10(3):1501-1506. doi: 10.3892/ol.2015.3434. Epub 2015 Jun 29. Oncol Lett. 2015. PMID: 26622698 Free PMC article.

2

shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells.

Yang H, Lu Y, Zheng Y, Yu X, Xia X, He X, Feng W, Xing L, Ling Z. Yang H, et al. Among authors: feng w. Cancer Chemother Pharmacol. 2014 Mar;73(3):569-76. doi: 10.1007/s00280-014-2379-y. Epub 2014 Jan 22. Cancer Chemother Pharmacol. 2014. PMID: 24448637

3

Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.

Yang H, He X, Zheng Y, Feng W, Xia X, Yu X, Lin Z. Yang H, et al. Among authors: feng w. Chem Biol Drug Des. 2014 Nov;84(5):578-84. doi: 10.1111/cbdd.12348. Epub 2014 Jul 12. Chem Biol Drug Des. 2014. PMID: 24775638

4

ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis.

Wang C, Liang C, Feng W, Xia X, Chen F, Qiao E, Zhang X, Chen D, Ling Z, Yang H. Wang C, et al. Among authors: feng w. Int J Mol Med. 2017 Apr;39(4):1037-1045. doi: 10.3892/ijmm.2017.2913. Epub 2017 Mar 9. Int J Mol Med. 2017. PMID: 28290601

5

Knockdown of ribosomal protein S15A inhibits proliferation of breast cancer cells through induction of apoptosis in vitro.

Feng W, Liang C, Wang C, Yu X, Li Q, Yang H. Feng W, et al. Cytotechnology. 2018 Oct;70(5):1315-1323. doi: 10.1007/s10616-018-0221-9. Epub 2018 May 25. Cytotechnology. 2018. PMID: 29802490 Free PMC article.

6

The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells.

Feng W, Wang C, Liang C, Yang H, Chen D, Yu X, Zhao W, Geng D, Li S, Chen Z, Sun M. Feng W, et al. Cell Physiol Biochem. 2018;49(2):432-446. doi: 10.1159/000492978. Epub 2018 Aug 29. Cell Physiol Biochem. 2018. PMID: 30157476 Free article.

7

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World.

Yu X, Wang C, Zheng Y, Miao B, Hu J, Shao X, Sheng L, Lin J, Ding Y, Xuan H, Ding Y, Gong L, Feng W, Qin C, Chen D, Yu Y, Yang H. Yu X, et al. Among authors: feng w. Front Oncol. 2021 Jul 28;11:704842. doi: 10.3389/fonc.2021.704842. eCollection 2021. Front Oncol. 2021. PMID: 34395277 Free PMC article.

8

The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study.

Yu XF, Feng WL, Miao LL, Chen B, Yang HJ. Yu XF, et al. Breast. 2013 Oct;22(5):824-7. doi: 10.1016/j.breast.2013.02.005. Epub 2013 Mar 5. Breast. 2013. PMID: 23466329

9

Clinicopathological features of invasive lobular carcinoma of the breast: A nationwide multicenter study in China.

Zhu MZ, Yu XF, He XM, Feng WL, Fan JH, Li J, Xu F, Tang ZH, Zhang BN, Qiao YL, Zheng S, Yang HJ. Zhu MZ, et al. Among authors: feng wl. J Cancer Res Ther. 2015 Aug;11 Suppl 1:C89-94. doi: 10.4103/0973-1482.163851. J Cancer Res Ther. 2015. PMID: 26323933 Free article.

10

Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57^KIP2 and involving in p-p38 MAPK and NF-κB pathways.

Qiao E, Chen D, Li Q, Feng W, Yu X, Zhang X, Xia L, Jin J, Yang H. Qiao E, et al. Among authors: feng w. J Cell Biochem. 2019 Mar;120(3):3978-3988. doi: 10.1002/jcb.27680. Epub 2018 Oct 30. J Cell Biochem. 2019. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S33. doi: 10.1002/jcb.29992 PMID: 30378143 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,128 results

Search Page

Filters